Tobacco Cessation and Low Dose CT Lung Cance Screen have the ability to reduce the burden of Lung Cancer Mortality. This page is dedicated to providing up-to-date resources and information to aid providers in their endeavor to help in cessation and screening decisions with their at risk patients.
Resources:
-
American Thoracic Society evidence-based lung cancer Decision Aid for patients - Physicians, hospitals and healthcare systems can order copies of the brochure for their screening programs. The cost is $10 each for ATS members and $15 each for nonmembers (plus shipping). To order copies, please contact Diane Gern: dgern@thoracic.org or 212-315-6441.
Statements:
-
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. M. Patricia Rivera , Nichole T. Tanner , Gerard A. Silvestri , Frank C. Detterbeck , Martin C. Tammemägi , Robert P. Young , Christopher G. Slatore , Tanner J. Caverly , Cynthia M. Boyd , Dejana Braithwaite , Joelle T. Fathi , Michael K. Gould , Jonathan M. Iaccarino , Stephen P. Malkoski , Peter J. Mazzone , Lynn T. Tanoue , Nancy L. Schoenborn , Javier J. Zulueta , and Renda Soylemez Wiener ; on behalf of the American Thoracic Society Assembly on Thoracic Oncology. Am J Respir Crit Care Med. 2018 Jul 15;198(2):e3-e13. doi: 10.1164/rccm.201805-0986ST.
-
Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. Kathuria H, Detterbeck FC, Fathi JT, Fennig K, Gould MK, Jolicoeur DG, Land SR, Massetti GM, Mazzone PJ, Silvestri GA, Slatore CG, Smith RA, Vachani A, Zeliadt SB, Wiener RS; ATS Assembly on Thoracic Oncology. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1202-1212. doi: 10.1164/rccm.201709-1858ST.
-
Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement. Mazzone PJ, Sears CR, Arenberg DA, Gaga M, Gould MK, Massion PP, Nair VS, Powell CA, Silvestri GA, Vachani A, Wiener RS; ATS Assembly on Thoracic Oncology. Am J Respir Crit Care Med. 2017 Oct 1;196(7):e15-e29. doi: 10.1164/rccm.201708-1678ST.
-
An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice. Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.
-
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould MK, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G. Chest. 2015 Feb;147(2):295-303. doi: 10.1378/chest.14-2500.
Journal Clubs, Webinars, and Podcasts:
- Journal Club 3/7/19 - Complication Rates and Downstream Medical Costs Associated with Invasive Diagnostic Procedures for Lung Abnormalities in the Community Setting
- OutOfTheBlue: Is CT Screening For Lung Cancer Generalizable To Older Patients? (BlueBriefing video)
- AnnalsATS Podcast: Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer
- Lung Cancer Screening Implementation: A Serial Discussion
- 20 minutes on Lung Cancer Screening
